Literature DB >> 25305139

Inflammatory burden interacts with conventional cardiovascular risk factors for carotid plaque formation in rheumatoid arthritis.

Churl Hyun Im1, Na Ri Kim1, Jong Wan Kang1, Ji Hun Kim1, Jin Young Kang1, Gi Bum Bae1, Eon Jeong Nam1, Young Mo Kang2.   

Abstract

OBJECTIVE: Patients with RA have an increased risk of atherosclerosis and cardiovascular (CV) diseases compared with the general population. The aim of this study was to evaluate the role of inflammatory burden in the formation of carotid plaques in patients with RA.
METHODS: We performed carotid artery US to measure the carotid intima-media thickness (IMT) and plaques in 406 patients with RA and 209 age- and sex-matched healthy controls. To assess the inflammatory burden, the area under the curve (AUC) of ESR over time was calculated.
RESULTS: The carotid plaque frequency and mean IMT were significantly increased in patients with RA relative to controls. After adjustment for age and gender, the presence of carotid plaques in patients with RA was associated with HAQ score, tender joint count (TJC), swollen joint count (SJC), 28-joint DAS, ESR, CRP, LEF use, current corticosteroid dose and the number of conventional CV risk factors. After multivariate regression analysis, the factors significantly associated with plaque formation were TJC (P = 0.002), ESR (P = 0.002) and the number of conventional CV risk factors (P = 0.041). Among 194 RA patients with ESR AUC data, the presence of carotid plaque was independently associated with both the ESR AUC and number of conventional CV risk factors, which showed a synergistic interaction.
CONCLUSION: Cumulative inflammatory burden contributes to the development of carotid atherosclerosis through a synergistic interaction with conventional CV risk factors in patients with RA.
© The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  atherosclerosis; inflammation; rheumatoid arthritis; risk factors; ultrasound

Mesh:

Substances:

Year:  2014        PMID: 25305139     DOI: 10.1093/rheumatology/keu376

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  23 in total

1.  Parasitic infection as a potential therapeutic tool against rheumatoid arthritis.

Authors:  Shadike Apaer; Tuerhongjiang Tuxun; Hai-Zhang Ma; Heng Zhang; Amina Aierken; Abudusalamu Aini; Yu-Peng Li; Ren-Yong Lin; Hao Wen
Journal:  Exp Ther Med       Date:  2016-09-05       Impact factor: 2.447

Review 2.  Cognitive impairment in elderly patients with rheumatic disease and the effect of disease-modifying anti-rheumatic drugs.

Authors:  Akhil Sood; Mukaila A Raji
Journal:  Clin Rheumatol       Date:  2020-08-30       Impact factor: 2.980

3.  Increased carotid intima-media thickness in rheumatoid arthritis: an update meta-analysis.

Authors:  Peng Wang; Shi-Yang Guan; Shu-Zhen Xu; Hong-Miao Li; Rui-Xue Leng; Xiang-Pei Li; Hai-Feng Pan
Journal:  Clin Rheumatol       Date:  2015-11-27       Impact factor: 2.980

Review 4.  Rheumatoid Arthritis: Atherosclerosis Imaging and Cardiovascular Risk Assessment Using Machine and Deep Learning-Based Tissue Characterization.

Authors:  Narendra N Khanna; Ankush D Jamthikar; Deep Gupta; Matteo Piga; Luca Saba; Carlo Carcassi; Argiris A Giannopoulos; Andrew Nicolaides; John R Laird; Harman S Suri; Sophie Mavrogeni; A D Protogerou; Petros Sfikakis; George D Kitas; Jasjit S Suri
Journal:  Curr Atheroscler Rep       Date:  2019-01-25       Impact factor: 5.113

5.  Evaluating the role of serum sclerostin as an indicator of activity and damage in Egyptian patients with rheumatoid arthritis: university hospital experience.

Authors:  Ahmed Fayed; Rasmia Elgohary; Mary Fawzy
Journal:  Clin Rheumatol       Date:  2019-12-21       Impact factor: 2.980

6.  Significant effects of biologic therapy on lipid profiles and insulin resistance in patients with rheumatoid arthritis.

Authors:  Der-Yuan Chen; Yi-Ming Chen; Tsu-Yi Hsieh; Chia-Wei Hsieh; Chi-Chen Lin; Joung-Liang Lan
Journal:  Arthritis Res Ther       Date:  2015-03-07       Impact factor: 5.156

7.  Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren's syndrome: prevalence, clinical and laboratory associations.

Authors:  Fotini Gravani; Ioanna Papadaki; Eleni Antypa; Andrianos Nezos; Kyriaki Masselou; Dimitrios Ioakeimidis; Michael Koutsilieris; Haralampos M Moutsopoulos; Clio P Mavragani
Journal:  Arthritis Res Ther       Date:  2015-04-11       Impact factor: 5.156

8.  Association of Cardiovascular Risk Factors with Carotid Intima Media Thickness in Patients with Rheumatoid Arthritis with Low Disease Activity Compared to Controls: A Cross-Sectional Study.

Authors:  Deborah F van Breukelen-van der Stoep; Derkjen van Zeben; Boudewijn Klop; Gert-Jan M van de Geijn; Hans J W Janssen; Mieke J M W Hazes; Erwin Birnie; Noelle van der Meulen; Marijke A De Vries; Manuel Castro Cabezas
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

Review 9.  Autoimmune Rheumatic Diseases: An Update on the Role of Atherogenic Electronegative LDL and Potential Therapeutic Strategies.

Authors:  Der-Yuan Chen; Tatsuya Sawamura; Richard A F Dixon; José Luis Sánchez-Quesada; Chu-Huang Chen
Journal:  J Clin Med       Date:  2021-05-06       Impact factor: 4.241

Review 10.  Cardiovascular Disease in Rheumatoid Arthritis: Risk Factors, Autoantibodies, and the Effect of Antirheumatic Therapies.

Authors:  Mir Sohail Fazeli; Vadim Khaychuk; Keith Wittstock; Boris Breznen; Grace Crocket; Mir-Masoud Pourrahmat; Leticia Ferri
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.